Antimicrobial peptides (AMPs) are a class of naturally occurring short peptide chains with a broad spectrum of biological activities, especially showing unique potential in cancer treatment. Its ability to selectively kill tumor cells makes it a research hotspot for anticancer therapy. However, the issues of stability, selectivity and toxicity of AMPs in clinical applications still need to be addressed. This review summarizes the current status of engineering and optimization design of antimicrobial peptides, focusing on ways to improve their biostability, anticancer selectivity and reduce host toxicity through chemical modification, sequence optimization and multifunctional strategies. Furthermore, the design concept of novel stimulus-responsive antimicrobial peptides and their application prospects in targeted therapy are presented. Future research should focus on intelligent design, development of integrated treatment platforms, and innovation in industrial production technologies. Through multidisciplinary collaboration and technological breakthroughs, antimicrobial peptides are expected to play a greater role in cancer therapy and other biomedical fields, providing new solutions for personalized medicine and precision therapy.
Keywords: Antimicrobial peptides; Cancer treatment; Chemical modification; Intelligent design; Novel stimulus-responsive antimicrobial peptides.
© King Abdulaziz City for Science and Technology 2026. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.